Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U7 small nuclear 129 pseudogene (RNU7-129P) is a predicted pseudogene related to the small nuclear U7 RNA family. Unlike the functional U7 snRNA—which is a critical component of the U7 small nuclear ribonucleoprotein (snRNP) complex and is essential for histone pre-mRNA processing—RNU7-129P does not encode a functional RNA product and is generally not expressed in cells[2][6]. Pseudogenes are typically non-functional copies of genes, sometimes described as "genomic relics"; they seldom have direct biological function, though some pseudogenes in other families act as regulatory elements. No specific function, disease association, or drug interaction has been documented for RNU7-129P[6]. Important note: If the intention is to study histone RNA maturation or related pathologies (e.g., Aicardi-Goutières syndrome), the relevant functional target is RNA, U7 small nuclear 1 (RNU7-1), not the pseudogene RNU7-129P[1][3].
None. There is no drug targeting RNU7-129P.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 129 pseudogene (RNU7-129P).